BAG1 and breast carcinoma: In the same study, high levels of cytoplasmic or nuclear BAG-1 immunostaining were present in 9 of 14 (64%) and 7 of 14 (50%) ductal carcinoma in situ (a pre-invasive form of breast cancer) specimens, respectively.